Zobrazeno 1 - 9
of 9
pro vyhledávání: '"D Mambo"'
Publikováno v:
2021 1st International Conference on Multidisciplinary Engineering and Applied Science (ICMEAS).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c16a06d54dbab3832f497faba328baa6
https://doi.org/10.1109/icmeas52683.2021.9692312
https://doi.org/10.1109/icmeas52683.2021.9692312
Publikováno v:
eBiomedik; Vol 9, No 1 (2021): eBiomedik
Multidrug Resistance Tuberculosis (MDR TB) is Mycobacterium tuberculosis resistance to the first line of antituberculosis drugs are rifampicin and isoniazid. Globally, in 2017 there were around 558.000 new cases (range, 483.000-639.000) resistant TB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ed4dad43c1d28f15c2b2a7f8f2a44f
https://doi.org/10.35790/ebm.v9i1.31949
https://doi.org/10.35790/ebm.v9i1.31949
Publikováno v:
eBiomedik; Vol 7, No 1 (2019): eBiomedik
Calculation of unit cost could give some information to healthcare policy. Broncho-pneumonia is a lung inflammation disease that occurs in around 30% of babies with high mortality risk. This study was aimed to determine the general depiction of unit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc989b3322f24890c95893baa1f8861
https://ejournal.unsrat.ac.id/index.php/ebiomedik/article/view/22219
https://ejournal.unsrat.ac.id/index.php/ebiomedik/article/view/22219
Publikováno v:
eBiomedik; Vol 6, No 2 (2018): eBiomedik
Bronchopneumonia is still one of the health problems worldwide due to its high mortality rate. The definitive treatment for this disease is antibiotics. However, the use of antibiotics in hospitals is 30-80% not for the right indication. This study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef88b9fed12e34ff8a908a43e1d8c5d4
https://ejournal.unsrat.ac.id/index.php/ebiomedik/article/view/22175
https://ejournal.unsrat.ac.id/index.php/ebiomedik/article/view/22175
Publikováno v:
eBiomedik; Vol 5, No 2 (2017): eBiomedik
Callyspongia sp. is a kind of marine sponges that produces secondary metabolites, such as steroids, alkaloids, flavonoids, and terpenoids which can be used as antibacterial agents. This study was aimed to determine the inhibition activity of Callyspo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0f3681c2ef8958c233bf53c5beafc0a
https://ejournal.unsrat.ac.id/index.php/ebiomedik/article/view/18478
https://ejournal.unsrat.ac.id/index.php/ebiomedik/article/view/18478
Publikováno v:
eBiomedik; Vol 5, No 2 (2017): eBiomedik
Indonesia has the greatest marine biodiversity due to its coral reef ecosystem. Callyspongia aerizusa is a type of sponges that has bioactive potential as antibacterial, anticancer, and antifungal that has not been widely used. This study was aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6916266f8436cf3a88eb18acef00bc3
https://doi.org/10.35790/ebm.5.2.2017.18480
https://doi.org/10.35790/ebm.5.2.2017.18480
Autor:
D Williamson, E Abdalla, A Alexandre, R Bonnefille, G Buchet, C Carcaillet, M Decobert, M Delalande, C Descolas, P Farjon, K Fontijn, F Gasse, G Ernst, C Hely-Alleaume, D Jolly, Y Garcin, B Gwambene, V Grossi, A Issah, M Jenk, S Kajula, C Kinabo, R Kangalawe, E Liwenga, M A H Maboko, D Mambo, I Marohbe, O Merdaci, R De Mesmay, E Mwandapile, J C Parisot, C Quantin, O Radakovitch, P Schäffer, R Sokoni, F Sheshambo, F Sylvestre, M Taieb, F Thevenon, N Thouveny, B Turcq, F Vadeboin, J Vendé, Masoko Village
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9194f5a6df44f84c88aec971e919391
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.